Top compounds associated with response to CTD-2132N18.3


Feature Type Standardized
Nominal ANOVA
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.19 5e-07
mRNA KPT185 CTRPv2 pan-cancer AAC -0.2 4e-06
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.16 8e-06
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA NSC632839 CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA vincristine CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA tosedostat CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.13 0.0004
Download CSV